RELATED CONTENT
NEWS
- Amylin's Bydureon endures rejection; finally embraced by FDA
- Amylin, Lilly call it quits with exenatide to resolve legal dispute
- Full QT study for once-weekly Bydureon comes out clean, as expected, paving way for NDA resubmission
- Upcoming Bydureon US resubmission fails to boost Amylin
EVENTS
07 June 2012
The Rembrandt Hotel, London
12 June 2012
Annecy, France
18 June 2012
Boston Convention & Exhibition Center, Boston, MA
JOB OF THE WEEK

Section Head (m/f)
DRA International/CIS Section

Section Head (m/f)
DRA International/CIS Section

